You are searching for: Phase 2 Trial

No Structure Available Drug Name Sirukumab
Drug Type Monoclonal antibody
Drug Status Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
TTD Drug ID D03RIX Drug Info
No Structure Available Drug Name Clazakizumab
Drug Type Monoclonal antibody
Drug Status Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
TTD Drug ID D03UEO Drug Info
No Structure Available Drug Name rhACE2
Drug Type Protein/peptide drug
Drug Status Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
TTD Drug ID D0RB6L Drug Info
Drug Name PUL-042
Drug Type Protein/peptide drug
Drug Status Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
TTD Drug ID D0BR8X Drug Info
No Structure Available Drug Name Lopinavir + ritonavir + ribavirin + interferon beta-1b
Drug Type Combination drug
Drug Status Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
TTD Drug ID D0GW4K Drug Info
No Structure Available Drug Name Rintatolimod
Drug Type Protein/peptide drug
Drug Status Phase 1/2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
TTD Drug ID D0C5MT Drug Info
No Structure Available Drug Name Meplazumab
Drug Type Monoclonal antibody
Drug Status Phase 1/2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
TTD Drug ID D03EOF Drug Info
No Structure Available Drug Name TJ003234
Drug Type Monoclonal antibody
Drug Status Phase 1/2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
TTD Drug ID D02ZXK Drug Info
Drug Name SPI-1005
Drug Type Small molecular drug
Drug Status Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
TTD Drug ID D0J6GJ Drug Info
Drug Name Disulfiram
Drug Type Small molecular drug
Drug Status Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19) ; Middle East Respiratory Syndrome (MERS)
TTD Drug ID D0P4BC Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.